Logo

American Heart Association

  2
  0


Final ID: MDP1485

A Deep Learning Digital Biomarker for Mitral Valve Prolapse using Echocardiogram Videos

Abstract Body (Do not enter title and authors here): Background
Mitral valve prolapse (MVP) has a prevalence of 2–3% and is a risk factor for heart failure and sudden death, but MVP diagnosis by transthoracic echocardiography (TTE) requires time and clinical expertise. We trained a deep learning model to classify MVP from TTE videos.

Methods
DROID-MVP is a convolutional neural network trained to classify MVP using echocardiographer labels using 973,531 digital videos (parasternal long axis and apical views) from 45,657 studies performed in 15,728 cardiology patients at Massachusetts General Hospital. We validated DROID-MVP in 1,726 cardiology patients (4,869 studies) and 8,903 primary care patients (8,903 studies), and tested associations between predicted MVP score (range 0-1) and mitral regurgitation (MR) severity and left atrial (LA) anterior-posterior diameter in primary care patients with available measurements.

Results
Of 15,728 patients (6,029 [38%] women; mean age at first TTE 61 ± 17 years) in the training set, 729 (4.6%) had at least 1 study with MVP. DROID-MVP identified MVP in both the cardiology (area under the receiver operating characteristic curve [AUC] 0.955 [95% confidence interval: 0.939-0.970]; average precision [AP] 0.716 [0.649-0.776]; prevalence 0.035) and primary care (AUC 0.966 [0.955-0.978]; AP 0.668 [0.601-0.730]; prevalence 0.022) test sets (Figure 1). Discrimination persisted across strata of MR severity (AUC range 0.877-0.987). High (>0.67) vs low (<0.33) MVP score was associated with higher odds of moderate/severe MR (odds ratio 20.1 [12.2-33.4], p<0.001) and higher LA diameter (2.7 [0.9-4.4] mm, p<0.001; Figure 2), after adjusting for age, sex, height, and weight.

Conclusions
A deep learning model identifies MVP from TTE videos with excellent discrimination and higher model predictions are associated with greater MR severity and LA size. Our work demonstrates how deep learning can automate MVP diagnosis and may serve as a digital biomarker of MVP-associated structural abnormalities.
  • Al-alusi, Mostafa  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Khurshid, Shaan  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Sanborn, Danita  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Picard, Michael  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Ho, Jennifer  ( Beth Israel Deaconess Medical Center , Boston , Massachusetts , United States )
  • Maddah, Mahnaz  ( Broad Institute of MIT and Harvard , Cambridge , Massachusetts , United States )
  • Ellinor, Patrick  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Lau, Emily  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Small, Aeron  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Reeder, Christopher  ( Broad Institute of MIT and Harvard , Cambridge , Massachusetts , United States )
  • Shnitzer Dery, Tal  ( Broad Institute of MIT and Harvard , Cambridge , Massachusetts , United States )
  • Andrews, Carl  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Kany, Shinwan  ( Broad Institute of MIT and Harvard , Cambridge , Massachusetts , United States )
  • Ramo, Joel  ( Broad Institute of MIT and Harvard , Cambridge , Massachusetts , United States )
  • Haimovich, Julian  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Mostafa Al-Alusi: DO NOT have relevant financial relationships | Shaan Khurshid: DO NOT have relevant financial relationships | Danita Sanborn: No Answer | Michael Picard: DO have relevant financial relationships ; Consultant:Techtonic Therapeutic:Active (exists now) ; Consultant:Vertex Pharmaceuticals:Active (exists now) | Jennifer Ho: DO have relevant financial relationships ; Individual Stocks/Stock Options:Pfizer:Active (exists now) | Mahnaz Maddah: DO NOT have relevant financial relationships | Patrick Ellinor: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bayer AG:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Consultant:Bayer AG:Active (exists now) | Emily Lau: DO have relevant financial relationships ; Advisor:Astellas Pharma:Past (completed) | Aeron Small: DO NOT have relevant financial relationships | Christopher Reeder: No Answer | Tal Shnitzer Dery: DO NOT have relevant financial relationships | Carl Andrews: DO NOT have relevant financial relationships | Shinwan Kany: DO NOT have relevant financial relationships | Joel Ramo: DO NOT have relevant financial relationships | Julian Haimovich: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Advances in Native and Replaced Valves Care Research

Monday, 11/18/2024 , 11:10AM - 12:35PM

Moderated Digital Poster Session

More abstracts on this topic:
Balloon-Expandable versus Self-Expandable Valve for the Management of Bicuspid Aortic Disease: An Updated Meta-Analysis of Clinical Outcomes

Oliveira Izadora, Graner Moreira Humberto, De Sousa Andre, Paiva Arthur, Ferreira Vitor, De Sá Carlos Eduardo, Alves Alencar Joao Victor, Alves Alencar Pedro Lucas, Duarte Lima Ana Paula, Oliveira Vinicius

Acceptability and Gain of Knowledge of Community Educational Tools About Rheumatic Heart Disease Integrated With Screening In Low-Income Settings

Abrams Jessica, Nunes Maria, Diniz Marina, Fraga Lucas, Paula Luiza, Coelho Cecilia, Tacuri Chavez Luz Marina, Lemos Larissa, Correia Julliane, Ribeiro Antonio, Nascimento Bruno, Sable Craig, Spaziani Alison, Zuhlke Liesl, Cardoso Clareci, Vinhal Wanessa, Ribeiro Isabely, Oliveira Kaciane, Amaral Ingred Beatriz

More abstracts from these authors:
Prediction of Incident Atrial Fibrillation Using Handheld Single-Lead Electrocardiograms from the VITAL-AF Trial

Khurshid Shaan, Atlas Steven, Maddah Mahnaz, Singer Daniel, Ellinor Patrick, Friedman Sam, Al-alusi Mostafa, Kany Shinwan, Anderson Christopher, Ho Jennifer, Mcmanus David, Ashburner Jeffrey, Lubitz Steven

Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials

Cunningham Jonathan, Vardeny Orly, Lewis Eldrin, Pfeffer Marc, Jhund Pardeep, Desai Akshay, Mcmurray John, Ellinor Patrick, Ho Jennifer, Solomon Scott, Marti Castellote Pablo-miki, Reeder Christopher, Singh Pulkit, Lau Emily, Khurshid Shaan, Batra Puneet, Lubitz Steven, Maddah Mahnaz

You have to be authorized to contact abstract author. Please, Login
Not Available